Parkinson syndrome: Heterogeneity of etiology; heterogeneity of pathogenesis?

Neurology

Volumn 79, Issue 3, 2012, Pages 202-203

  Albin, Roger L ^a,c   Dauer, William T ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VAAAHS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; GLUCOSYLCERAMIDASE;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; EDITORIAL; EVIDENCE BASED PRACTICE; GENE MUTATION; GENETIC DISORDER; GENETIC HETEROGENEITY; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; STRIATONIGRAL DEGENERATION;

EID: 84866129072     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31825dd3d0     Document Type: Editorial

References (6)

1. Shimada H, Hirano S, Shinotoh H, et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 2009;73:273-278.
2. Vives-Bauza C, Tocilescu M, Devries RL, Alessi DM, Jackson-Lewis V, Przedborski S. Control of mitochondrial integrity in Parkinson's disease. Prog Brain Res 2010;183:99-113.
3. Brockmann K, Hilker R, Pilatus U, et al. GBA-associated PD: neurodegeneration, altered membrane metabolism, and lack of energy failure. Neurology 2012;79:213-220.
4. Hattingen E, Magerkurth J, Pilatus U, et al. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. Brain 2009;132:3285-3297.
5. Mazzulli JR, Xu YH, Sun Y, et al. Alpha-synuclein interacts with Gaucher disease glucocerebrosidase and a-synuclein form a bidirectional pathogenic loop in. synucleinopathies Cell 2011;146:37-52.
6. Corti O, Lesage S, Brice A. What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol Rev 2011;91:1161-1218.